A clinical study to evaluate the efficacy of Mahishakhyo Guggul in Vatrakta with special reference to Gout

Randomised Open Controlled Clinical Study to evaluate the efficacy of Mahishakhyo Guggul in Vatrakta with special reference to Gout - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/103095

Enrollment

Registered

2026-02-05

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having serum uric acid level more than 7mg/dl in male and more and 6mg/ dl in female. Patient presenting Toda Shotha and Sthabdhata in relation to Parvasandhi. Patient who has agreed to give written consent.

Exclusion criteria

Exclusion criteria: Known case of Amavata, Sandhigatvata , SLE. Patient on chronic use of NSAIDS and steroidal inflammatory drugs. Pregnancy, Lactating mothers. Patients prediagnosed with autoimmune diseases of joint. Patients associated with metabolic disorders and systemic diseases.

Design outcomes

Primary

Measure	Time frame
To study the efficacy of Mahishakhyo Guggul 500mg twice a day with koshnajala in vatarakta.Timepoint: 30 days	—

Secondary

Measure	Time frame
1.To evaluate efficacy of Mahishakhyo guggul for 30 days in lakshana of toda daha kandu sfuran shotha stabdhata twaka krushna in vatrakta patients. 2.To assess the reduction of uric acid level after mahishakhyo guggul for 30 days in vatrakta patients. 3.To assess the outcome of study after 30th day.Timepoint: 30 days	—

Countries

India

Contacts

Public ContactDr Dipali Swami

Yashwant Ayurvedic College Post Graduate Training and Research Centre Kodoli

drdipaliswamis@gmail.com9960003947

Outcome results